* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Advanced Enzyme Technologies's PEG Ratio or its related term are showing as below:
NSE:ADVENZYMES'
s PEG Ratio Range Over the Past 10 Years
Min: 0.97 Med: 2.63 Max: 29.97
Current: 10.73
During the past 13 years, Advanced Enzyme Technologies's highest PEG Ratio was 29.97. The lowest was 0.97. And the median was 2.63.
NSE:ADVENZYMES's PEG Ratio is ranked worse than 87.66% of 713
companies
in the Chemicals industry
Industry Median: 1.9
vs NSE:ADVENZYMES: 10.73
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Advanced Enzyme Technologies PEG Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Advanced Enzyme Technologies's PEG Ratio
For the Specialty Chemicals subindustry, Advanced Enzyme Technologies's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Advanced Enzyme Technologies's PEG Ratio Distribution in the Chemicals Industry
For the Chemicals industry and Basic Materials sector, Advanced Enzyme Technologies's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Advanced Enzyme Technologies's PEG Ratio falls into.
Advanced Enzyme Technologies PEG Ratio Calculation
PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio.
The ratio we use is the 5-Year EBITDA growth rate.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Advanced Enzyme Technologies (NSE:ADVENZYMES) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Advanced Enzyme Technologies PEG Ratio Related Terms
Thank you for viewing the detailed overview of Advanced Enzyme Technologies's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Advanced Enzyme Technologies (NSE:ADVENZYMES) Business Description
Advanced Enzyme Technologies Ltd is an Indian company engaged in research activities to manufacture and sell enzymes. The Company operates only in one business segment viz. manufacturing and sales of enzymes. The company offers enzymes for human healthcare and nutrition, animal nutrition, food processing, and non-food processing. Some of the products offered by the company are serratiopeptidase, fungal lipase, papain, hemicellulose, and digegrain, among others. Geographically, the entity operates in India, Europe, the USA, Asia, and other countries, of which a majority of the revenue is derived from India.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NSE:ADVENZYMES has been successfully added to your 